Acuvail
Showing 1 - 16 of 16
Diabetic Retinopathy Trial in Nashville (Ketorolac 0.45% ophthalmic solution, Placebo - Preservative-free artificial tears,
Recruiting
- Diabetic Retinopathy
- Ketorolac 0.45% ophthalmic solution
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 16, 2022
NSCLC, Renal Cell Carcinoma Trial in Atlanta (Preoperative Ketorolac)
Recruiting
- Non-small Cell Lung Cancer
- Renal Cell Carcinoma
- Preoperative Ketorolac
-
Atlanta, Georgia
- +3 more
Sep 16, 2021
Retinopathy of Prematurity Trial in Brooklyn (Caffeine citrate, Ibuprofen, Ketorolac)
Completed
- Retinopathy of Prematurity
- Caffeine citrate
- +2 more
-
Brooklyn, New YorkSUNY Downstate Medical Center/University Hospital of Brooklyn
Apr 21, 2020
Cross-linking of Corneal Collagen With Ultraviolet-A in
Terminated
- Keratoconus
- +2 more
- Ciprofloxicin or Vigamox or other.
- +2 more
-
Scottsdale, Arizona
- +15 more
Oct 10, 2018
Total Hip Arthroplasty Trial in Rochester (PNB Bupivacaine, PAI Ropivacaine, PAI liposomal bupivacaine)
Completed
- Total Hip Arthroplasty
- PNB Bupivacaine
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 21, 2018
Post-surgical Cystoid Macular Edema (PSCME) Trial in Baltimore (PredA + Kelac)
Completed
- Post-surgical Cystoid Macular Edema (PSCME)
- PredA + Kelac
-
Baltimore, MarylandWilmer Eye Institute
Aug 18, 2017
Inflammation Trial in Nashville (Acuvail, Placebo)
Withdrawn
- Inflammation
- Acuvail
- Placebo
-
Nashville, TennesseeVanderbilt Eye Institute
Feb 20, 2017
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Terminated
- Keratoconus
- +2 more
-
San Diego, California
- +4 more
Oct 10, 2018
Total Knee Arthroplasty, Pain Management Trial (Cocktail, Exparel, Marcaine)
Withdrawn
- Total Knee Arthroplasty
- Pain Management
- Cocktail
- +2 more
- (no location specified)
Apr 5, 2017
Osteoarthritis, Pain Trial in Boston (Exparel, Femoral Nerve Block Bupivacaine, Toradol)
Unknown status
- Osteoarthritis
- Pain
- Exparel
- +3 more
-
Boston, MassachusettsNew England Baptist Hospital
Mar 16, 2016
Cystoid Macular Edema, Postoperative, Diabetes Trial in Kuala Lumpur (Ketorolac tromethamine ophthalmic solution 0.45%)
Completed
- Cystoid Macular Edema, Postoperative
- Diabetes Mellitus
- Ketorolac tromethamine ophthalmic solution 0.45%
-
Kuala Lumpur, Wilayah Persekutuan, MalaysiaUniversity of Malaya
Jan 4, 2016
Age-related Macular Degeneration, Central Retinal Vein Occlusion, Diabetic Macular Edema Trial in Clearwater (Xylocaine 2%
Completed
- Age-related Macular Degeneration
- +2 more
- Xylocaine 2% Injectable Anesthetic
- +4 more
-
Clearwater, FloridaRetina Vitreous Associates of Florida
Apr 18, 2014
ACUVAILâ„¢ 0.45%, in Post-PRK Corneal Wound Healing
Completed
- Must be PRK Candidate
-
Overland Park, KansasDurrie Vision
Feb 13, 2012
Cataracts Trial in Wilkes-Barre (Ketorolac Tromethamine 0.45%, bromfenac 0.09%, nepafenac 0.1%)
Completed
- Cataracts
- Ketorolac Tromethamine 0.45%
- +2 more
-
Wilkes-Barre, PennsylvaniaBucci Laser Vision Institute
Aug 26, 2011
Post Operative Anterior Chamber Inflammation (Flare) Trial in Wilkes-Barre (Ketorolac Tromethamine 0.45%, Bromfenac 0.09%)
Completed
- Post Operative Anterior Chamber Inflammation (Flare)
- Ketorolac Tromethamine 0.45%
- Bromfenac 0.09%
-
Wilkes-Barre, PennsylvaniaBucci Laser Vision Institute
Jul 28, 2011